ResearcherJiangnan UniversityNo recent work listed

Haiyan Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0868-3606; OpenAlex author ID A5031306882. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper

Papers 2

JF-305, a pancreatic cancer cell line is highly sensitive to the PARP inhibitor olaparib. Co-author DOI 10.3892/ol.2014.2762 ↗
Cutaneous metastasis from pancreatic cancer: A case report and systematic review of the literature. Co-author DOI 10.3892/ol.2014.2610 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xueli Yang · 1 shared paper, 2015 · strength 0.06
- Paper JF-305, a pancreatic cancer cell line is highly sensitive to the PARP inhibitor olaparib. DOI 10.3892/ol.2014.2762 ↗
Jian Jin · 1 shared paper, 2015 · strength 0.06
- Paper JF-305, a pancreatic cancer cell line is highly sensitive to the PARP inhibitor olaparib. DOI 10.3892/ol.2014.2762 ↗
Zhehai Wang · 1 shared paper, 2014 · strength 0.05
- Paper Cutaneous metastasis from pancreatic cancer: A case report and systematic review of the literature. DOI 10.3892/ol.2014.2610 ↗
Shu Zhang · 1 shared paper, 2014 · strength 0.05
- Paper Cutaneous metastasis from pancreatic cancer: A case report and systematic review of the literature. DOI 10.3892/ol.2014.2610 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.